IUIS-Frontiers COVID-19 webinar series
The International Union of Immunological Societies (IUIS) is collaborating with Frontiers to accelerate the development of novel diagnostics, therapeutics and vaccines against coronavirus.
Watch our weekly series of expert commentaries and scientific webinars – and stay tuned for new article collections on COVID-19 from world-leading researchers.
Be part of this collaboration by sending your abstract for a webinar and/or a Research Topic. »Send abstract
Solutions to the coronavirus pandemic
COVID-19 IMMUNOLOGY
Michael Reth, University of Freiburg
20 July 2020 | Using Ramos B cells where the B cell antigen receptor is replaced by the spike protein of SARS-CoV-2, Michael Reth and his team are investigating spike-specific antibody responses and monoclonal antibodies by flow cytometry.
COVID-19 IMMUNOLOGY
Adrian Hayday, King’s College London
13 July 2020 | New research on the immune response reveals possible early warning signs for severe COVID-19 symptoms. Prof Adrian Hayday, of King’s College London, shares emerging results from an immunophenotyping of over 100 patients and controls.
Watch his expert commentary for a summary »Watch video
COVID-19 IMMUNOLOGY
Hans-Martin Jäck, University of Erlangen-Nuremberg
6 July 2020 | Hans-Martin Jäck summarizes the COVID-19 pandemic and CoV-2-host cell interactions, provides an overview of the current clinical serum and vaccine trials, and reviews the production of human CoV-2 neutralizing antibodies in transgenic mice with an entirely human antibody repertoire.
COVID-19 EPIDEMIOLOGY
Salim Abdool Karim, CAPRISA
24 June 2020 | How can South Africa control the spread of COVID-19 as it eases its unsustainable lockdown measures? Prof Salim Abdool Karim, Director of the Centre for the AIDS Program of Research in South Africa, outlines the challenge facing the country.
Watch his expert commentary for a summary »Watch video
CORONAVIRUS TREATMENT
Eric Vivier, Aix Marseille University & Innate Pharma
17 June 2020 | Levels of immune complement component C5a correlate with COVID-19 severity – and blocking its actions may provide a new treatment, explains Eric Vivier from Aix Marseille University and Innate Pharma.
Watch his expert commentary for a summary »Watch video
CORONAVIRUS IMMUNITY
Lisa Ng, A*STAR
15 June 2020 | Lisa Ng from A*STAR's Singapore Immunology Network outlines different detection methods for SARS-CoV-2, considerations in their development, and how the results will help to shed light on the epidemiology of COVID-19. Hear more from Lisa Ng in a webinar on SARS-CoV-2 pathophysiology, diagnostics and therapies: link coming soon.
CORONAVIRUS IMMUNITY
Donna Farber, Columbia University
8 June 2020 | Donna Farber from Columbia University discusses lung-localized immune responses to SARS-CoV2 infection as well as work to identify potential immune correlates of disease severity in COVID-19.
Watch her expert commentary for a summary »Watch video
CORONAVIRUS IMMUNITY
Sharon Lewin & Katherine Kedzierska, Peter Doherty Institute
27 May 2020 | Sharon Lewin and Katherine Kedzierska from the Peter Doherty Institute for Infection and Immunity show how Australia “flattened the curve” and discuss immune responses in patients with mild to moderate COVID-19.
CORONAVIRUS VACCINE
Mihai Netea, Radboud University
18 May 2020 | The BCG vaccine for tuberculosis also provides protection against respiratory viruses. Mihai Netea from the Radboud University Medical Center discusses whether BCG-induced trained immunity could be harnessed against COVID-19.
Watch his expert commentary for a summary »Watch video
CORONAVIRUS IMMUNITY
Andreas Radbruch, DRFZ
11 May 2020 | The body's adaptive immune system is very powerful – but vaccination against SARS-CoV-2 will give stronger, more reliable protection, explains Andreas Radbruch, Scientific Director at Deutsches Rheuma-Forschungszentrum (DRFZ) Berlin.
Watch his expert commentary for a summary »Watch video
COVID-19 TREATMENT
Rachel Humphrey, TIO Bioventures
4 May 2020 | Hear how treatments for side effects of some cancer immunotherapies – especially those to lower levels of cytokine IL-6 – show promise for COVID-19 patients, with Rachel Humphrey, Head of R&D at TIO Bioventures.
Watch her expert commentary for a summary »Watch video
COVID-19 TREATMENT
Eleanor Fish, University of Toronto
27 April 2020 | Eleanor Fish shares exploratory data on treating COVID-19 patients with interferon-alpha, following previous work showing that treatment with interferon-alpha was beneficial in patients with SARS. Eleanor is Professor in the Department of Immunology at the University of Toronto, Canada.
Watch her expert commentary for a summary »Watch video
CORONAVIRUS POLICY
Giuseppe Ippolito, National Institute for Infectious Disease
24 April 2020 | Giuseppe Ippolito discusses policy responses to the coronavirus pandemic and the investments needed to prepare against future infectious diseases. Giuseppe is Scientific Director at the National Institute for Infectious Diseases in Rome, Italy.
Watch his expert commentary for a summary »Watch video
CORONAVIRUS VACCINE
Rino Rappuoli, GSK
3 April 2020 | How long will it really take to develop a vaccine for COVID-19, and how is science speeding up the process? Rino Rappuoli, Chief Scientist and Head of Research & Development at GlaxoSmithKline, shares his thoughts and answers questions.
Watch his expert commentary for a summary »Watch video
COLLABORATION
Faith Osier, IUIS
26 March 2020 | Faith Osier, President of the International Union of Immunological Societies (IUIS), calls on researchers to share knowledge and resources to halt the coronavirus (COVID-19) pandemic.
Send your abstract to be part of this collaboration between IUIS and Frontiers.
